AI assistant
Sending…
CONMED Corp — Director's Dealing 2018
Sep 4, 2018
31971_dirs_2018-09-04_b43c4566-d6fa-413e-bd46-87f1604708a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2018-08-31
Reporting Person: SHAGORY PETER K (EVP, STRAT & CORP DEVT)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-31 | Common Stock | M | 2500 | $39.87 | Acquired | 3655 | Direct |
| 2018-08-31 | Common Stock | S | 2500 | $80.00 | Disposed | 1155 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-08-31 | Options To Purchase Common Stock | $39.87 | M | 2500 | Disposed | 2026-03-01 | Common Stock (2500) | Direct |
Footnotes
F1: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7